Science
Science at the Core
Scientific integrity and regulatory compliance are foundational to everything we do at Boli.
We develop clinically validated, regulatory-grade digital therapeutics (DTx) – because that’s the only way to earn the trust of physicians, be integrated into care pathways, and contribute meaningfully to medical research.
We are building a new model of care, grounded in science, to support what we believe is the next frontier in chronic disease: metabolic health.
Two Global Pandemics:
Obesity & Diabetes
The numbers are staggering. But beyond these numbers, these conditions reduce life expectancy and drive the global burden of cardiovascular, hepatic, renal, and mental health disorders.
Two Global Pandemics:
Diabetes & Obesity
The numbers are staggering. But beyond these numbers, these conditions reduce life expectancy and drive the global burden of cardiovascular, hepatic, renal, and mental health disorders.
It’s Not Your Fault.
It’s Your Metabolism.
Obesity and type 2 diabetes have been blamed on willpower for too long.
It’s not a lack of discipline – it’s a metabolic imbalance.
It’s biology, not failure.
It’s not your fault.
With the right tools and support, you can take back control.
That’s what Boli is for: helping you understand your metabolism and build lasting health – at your pace, without shame.
It’s Not Your Fault.
It’s Your Metabolism.
Obesity and type 2 diabetes have been blamed on willpower for too long.
But it’s not a lack of discipline – it’s a metabolic imbalance.
It’s biology, not failure.
It’s not your fault.
With the right tools and support, you can take back control.
That’s what Boli is for: helping you understand your metabolism and build lasting health – at your pace, without shame.
GLP-1 Therapies:
A Breakthrough, With Limits
Patients need more than prescriptions.
They need support to optimize the benefits, manage side effects, and use this window of change to build lasting metabolic balance.
Yes,
GLP-1 agonists are trully changing the game:
- Proven reductions in HbA1c and weight
- Demonstrated cardiovascular benefits
- Widespread adoption in diabetes and obesity care
But:
Several factors reduce GLP-1 real-world effectiveness:
- Many patients experience side effects and discontinue
- High costs limit long-term access
- Without lifestyle change, automatic weight rebounds
Make GLP-1 work better to enhance metabolic health
Boli is a digital therapeutic designed to make GLP-1 therapies more effective, more sustainable, and more accessible. Evidence backs it. Digital health tools improve glycemic control and support better adherence.
Improve adherence & reduce side effects
Leverage the metabolic window
Built for Science. Built for Research.
Our DTx is a certified medical device (CE/FDA pending), designed not just to support care, but to generate high-quality real-world evidence (RWE).
For Science
By capturing structured, longitudinal metabolic data in GLP-1-treated patients, we will provide unique and extremely valuable insights for:
- Understanding real-life treatment trajectories
- Supporting market access and post-market surveillance
- Preparing for the next generation of GLP-1 therapies
For Research
Our data infrastructure is built to meet the highest standards: structured, anonymized, interoperable, and ready for clinical research. Multiple studies in the pipeline.
- Weight outcomes
- Treatment adherence
- Care pathway optimization